Jones Financial Companies
MED icon

Jones Financial Companies’s Medifast MED Stock Holding History

Jones Financial Companies’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.05K Sell
576
-36
-6% -$415 ﹤0.01% 4017
2026
Q1 		$5.97K Buy
612
+36
+6% +$388 ﹤0.01% 3774
2025
Q4 		$6.15K Buy
576
+410
+247% +$4.91K ﹤0.01% 3417
2025
Q3 		$2.28K Hold
166
– – ﹤0.01% 3650
2025
Q2 		$2.25K Sell
166
-84
-34% -$1.1K ﹤0.01% 3431
2025
Q1 		$3.46K Buy
250
+166
+198% +$2.49K ﹤0.01% 3077
2024
Q4 		$1.48K Hold
84
– – ﹤0.01% 3073
2024
Q3 		$1.61K Hold
84
– – ﹤0.01% 2717
2024
Q2 		$1.83K Buy
+84
New +$2.24K ﹤0.01% 2176

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jones Financial Companies's MED Position: Q2 2026 in Review

Jones Financial Companies reduced its Medifast (MED) stake by 5.9% in Q2 2026, selling an estimated $415 and leaving 576 shares worth $6.05K. The position accounts for ﹤0.01% of the portfolio, ranked #4017.

Jones Financial Companies first reported a position in MED in Q2 2024 and has held it in 9 quarters since. The position peaked at $6.15K in Q4 2025. 112 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • Jones Financial Companies held 576 shares of Medifast worth $6.05K as of Q2 2026.
  • Jones Financial Companies sold 36 Medifast shares in Q2 2026, an estimated $415.
  • Medifast made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4017 holding.
  • Jones Financial Companies first reported a position in Medifast in Q2 2024 and has held it in 9 quarters since.
  • Jones Financial Companies's Medifast position peaked at $6.15K in Q4 2025.
  • 112 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.